Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Excellent Outcomes in Patients with Primary and Secondary Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using a Rituximab, Busulfan, Melphalan, Thiotepa Conditioning Regimen

Shona Philip, BSc, MD, Adrienne Fulford, NP,MSN, Selay Lam, MDBSc,FRCPC, Chai Wye Phua, MD FRCPC, Joy Mangel, MD FRCPC, Kang Howson-Jan, MD FRCPC, Brandon Dorland, NP, MSN, Karen Atkinson, NP, MSN, Anargyros Xenocostas, MD FRCPC, Uday Deotare, MBBS, MD DM

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-139635

Published: 2020

Journal Articles

Reducing Cytogenetic Testing in the Era of Next Generation Sequencing (NGS); Are We Choosing Wisely?

Eri Kawata, MDPhD, Benjamin Hedley, PhD, Benjamin Chin-Yee, MD, Anargyros Xenocostas, MD FRCPC, Alejandro Lazo-Langner, MDMSc, Cyrus C. Hsia, MDBSc,FRCPC, Kang Howson-Jan, MD FRCPC, Ping Yang, PhD DABMGG, Michael Levy, PhD, Stephanie Santos, Chris Howlett, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-138667

Published: 2020

Journal Articles

The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas

Lakshman Vasanthamohan, MD FRCPC, Brent Parker, MD, Joy Mangel, MD FRCPC, Selay Lam, MDBSc,FRCPC, Kang Howson-Jan, MD FRCPC, Chai Wye Phua, MD FRCPC

Blood (2019) 134 (Supplement_1): 4131.

https://doi.org/10.1182/blood-2019-126997

Published: 2019

Journal Articles

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Alejandro Lazo-Langner, MD MSc, Kang Howson-Jan, MD FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Benjamin Hedley, PhD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2019) 134 (Supplement_1): 3438.

https://doi.org/10.1182/blood-2019-128507

Published: 2019

Journal Articles

Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia

Alejandro Garcia-Horton, MD, Rosanne St. Bernard, MD, Alejandro Lazo-Langner, MD MSc, Anargyros Xenocostas, MD, Joy Mangel, MD FRCPC, Kang Howson-Jan, MD FRCPC, Selay Lam, MDBSc, FRCPC, Cyrus C. Hsia, MDBSc, FRCPC

Blood (2018) 132 (Supplement 1): 5560.

https://doi.org/10.1182/blood-2018-99-120129

Published: 2018

Journal Articles

Treatment of Hodgkin Lymphoma without G-CSF Does Not Increase the Risk of Febrile Neutropenia.

Leonard A. Minuk, MD, FRCPC, Ian Chin-Yee, MD, FRCPC, Kang Howson-Jan, MD, FRCPC, Reinhard Lohmann, MD, FRCPC, Alejandro Lazo-Langner, MD MSC, Vinai C. Bhagirath, MD, Joy Mangel, MD, FRCPC

Blood (2009) 114 (22): 2502.

https://doi.org/10.1182/blood.V114.22.2502.2502

Published: 2009

NARROW

Excellent Outcomes in Patients with Primary and Secondary Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using a Rituximab, Busulfan, Melphalan, Thiotepa Conditioning Regimen

Reducing Cytogenetic Testing in the Era of Next Generation Sequencing (NGS); Are We Choosing Wisely?

The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia

Treatment of Hodgkin Lymphoma without G-CSF Does Not Increase the Risk of Febrile Neutropenia.

Email alerts

ASH Publications

American Society of Hematology

Excellent Outcomes in Patients with Primary and Secondary Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using a Rituximab, Busulfan, Melphalan, Thiotepa Conditioning Regimen

Reducing Cytogenetic Testing in the Era of Next Generation Sequencing (NGS); Are We Choosing Wisely?

The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

Safe Start of Ibrutinib in Patients with Chronic Lymphocytic Leukemia and Uncontrolled Autoimmune Hemolytic Anemia

Treatment of Hodgkin Lymphoma without G-CSF Does Not Increase the Risk of Febrile Neutropenia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only